» Articles » PMID: 28982826

Beliefs About Medicines and Non-adherence in Patients with Stroke, Diabetes Mellitus and Rheumatoid Arthritis: a Cross-sectional Study in China

Overview
Journal BMJ Open
Specialty General Medicine
Date 2017 Oct 7
PMID 28982826
Citations 91
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To investigate beliefs about medicines and their association with medicine adherence in patients with chronic diseases in China.

Design: A cross-sectional questionnaire-based study SETTING: Two large urban hospitals in Hefei and Tianjin, China PARTICIPANTS: Hospital inpatients (313 stroke patients) and outpatients (315 diabetic patients and 339 rheumatoid arthritis (RA) patients) were recruited between January 2014 and September 2014.

Outcome Measures: The Beliefs about Medicines Questionnaire (BMQ), assessing patients' beliefs about the specific medicine (Specific-Necessity and Specific-Concerns) prescribed for their conditions (stroke/diabetes/RA) and more general background beliefs about pharmaceuticals as a class of treatment (BMQ-General Benefit, Harm and Overuse); the Perceived Sensitivity to Medicines scale (PSM) assessed patients' beliefs about how sensitive they were to the effects of medicines and the Medication Adherence Report Scale. The association between non-adherence and beliefs about medicines was assessed using a logistic regression model.

Results: Patients with diabetes mellitus had a stronger perceived need for treatment (mean (SD) Specific-Necessity score, 3.75 (0.40)) than patients with stroke (3.69 (0.53)) and RA (3.66 (0.44)) (p=0.049). Moderate correlations were observed between Specific-Concerns and General-Overuse, General-Harm and PSM (Pearson correlation coefficients, 0.39, 0.49 and 0.49, respectively, p<0.01). Three hundred and eleven patients were non-adherent to their medicine (159 (51.0%) in the stroke group, 60 (26.7%) in the diabetes mellitus group and 62 (19.8%) in the RA group, p<0.01). Across the whole sample, after adjusting for demographic characteristics, non-adherence was associated with patients who had higher concerns about their medicines (OR, 1.35, 95% CI 1.07 to 1.71) and patients who believed that they were personally sensitive to the effects of medications (OR 1.44, 95% CI 1.16 to 1.85).

Conclusion: The BMQ is a useful tool to identify patients at risk of non-adherence. In the future, adherence intervention studies may use the BMQ to screen for patients who are at risk of non-adherence and to map interventional support.

Citing Articles

Enablers and Barriers to Medication Self-Management in Patients With Type 2 Diabetes: A Qualitative Study Using the COM-B Model.

Li H, Li Y, Wang J, Zhang Y, Ben S Patient Prefer Adherence. 2025; 19:485-501.

PMID: 40046565 PMC: 11881755. DOI: 10.2147/PPA.S503350.


Impact of the family doctor system on medication adherence among type 2 diabetes patients in China: a difference-in-differences analysis.

Tong X, Zou H, Zhang L, Chen W BMC Public Health. 2025; 25(1):404.

PMID: 39891108 PMC: 11786533. DOI: 10.1186/s12889-025-21656-0.


The risk factors and prediction model for postoperative pneumonia after craniotomy.

Xiang B, Yi M, Li C, Yin H, Wang S, Liu Y Front Cell Infect Microbiol. 2025; 14():1375298.

PMID: 39776439 PMC: 11703815. DOI: 10.3389/fcimb.2024.1375298.


Exploring the association of adverse drug reactions with medication adherence and quality of life among hypertensive patients: a cross-sectional study.

Insani W, Wei L, Abdulah R, Alfian S, Ramadhani N, Andhika R Int J Clin Pharm. 2024; .

PMID: 39607658 DOI: 10.1007/s11096-024-01832-9.


Analysis of risk factors and establishment of early warning model for recent postoperative complications of colorectal cancer.

Ou Y, Yang Y, Yang W, Pan Y, Tian W, Wang Z Front Oncol. 2024; 14:1411817.

PMID: 39568563 PMC: 11576315. DOI: 10.3389/fonc.2024.1411817.


References
1.
Lyons I, Barber N, Raynor D, Wei L . The Medicines Advice Service Evaluation (MASE): a randomised controlled trial of a pharmacist-led telephone based intervention designed to improve medication adherence. BMJ Qual Saf. 2016; 25(10):759-69. DOI: 10.1136/bmjqs-2015-004670. View

2.
Horne R, Parham R, Driscoll R, Robinson A . Patients' attitudes to medicines and adherence to maintenance treatment in inflammatory bowel disease. Inflamm Bowel Dis. 2008; 15(6):837-44. DOI: 10.1002/ibd.20846. View

3.
Horne R, Weinman J . Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 2000; 47(6):555-67. DOI: 10.1016/s0022-3999(99)00057-4. View

4.
Shore S, Carey E, Turakhia M, Jackevicius C, Cunningham F, Pilote L . Adherence to dabigatran therapy and longitudinal patient outcomes: insights from the veterans health administration. Am Heart J. 2014; 167(6):810-7. PMC: 5381802. DOI: 10.1016/j.ahj.2014.03.023. View

5.
Wei L, Wang J, Thompson P, Wong S, Struthers A, MacDonald T . Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study. Heart. 2002; 88(3):229-33. PMC: 1767352. DOI: 10.1136/heart.88.3.229. View